[Comparison of incident reporting and learning systems for radiation oncology in France and abroad].

Comparaison des systèmes de déclaration d’incidents en radiothérapie en France et à l’étranger.
Adverse events Experience feedback Incident learning system Radiotherapy Radiothérapie Retour d’expérience Safety Système de déclaration d’incidents Sécurité Événements indésirables

Journal

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272

Informations de publication

Date de publication:
May 2023
Historique:
received: 06 07 2022
revised: 20 09 2022
accepted: 22 09 2022
medline: 16 5 2023
pubmed: 13 2 2023
entrez: 12 2 2023
Statut: ppublish

Résumé

Reporting and learning are key components of quality and safety in radiotherapy. Each event must be reported to national authorities if considered significant according to national criteria. Lessons learnt from analysis of causal factors are primordial to decrease the risk of reoccurrence or the severity of further events. Thanks to national or international, mandatory or voluntary incidents reporting systems, and experience feedbacks, various sources of learning are available to improve risk management. This article aims to compare the regulations about mandatory declarations of significant events and describe national or international incident reporting and learning systems available.

Identifiants

pubmed: 36775779
pii: S1278-3218(23)00011-2
doi: 10.1016/j.canrad.2022.09.002
pii:
doi:

Types de publication

English Abstract Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

249-258

Informations de copyright

Copyright © 2023 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

Auteurs

M-N Nguyen (MN)

Département de radiothérapie, Institut de cancérologie Strasbourg Europe (Icans), 17, rue Albert-Calmette, BP 23025, 67033 Strasbourg, France.

I Chambrelant (I)

Département de radiothérapie, Institut de cancérologie Strasbourg Europe (Icans), 17, rue Albert-Calmette, BP 23025, 67033 Strasbourg, France.

P Meyer (P)

Département de radiothérapie, Institut de cancérologie Strasbourg Europe (Icans), 17, rue Albert-Calmette, BP 23025, 67033 Strasbourg, France.

L Tripard (L)

Département de radiothérapie, Institut de cancérologie Strasbourg Europe (Icans), 17, rue Albert-Calmette, BP 23025, 67033 Strasbourg, France.

D Antoni (D)

Département de radiothérapie, Institut de cancérologie Strasbourg Europe (Icans), 17, rue Albert-Calmette, BP 23025, 67033 Strasbourg, France.

G Noël (G)

Département de radiothérapie, Institut de cancérologie Strasbourg Europe (Icans), 17, rue Albert-Calmette, BP 23025, 67033 Strasbourg, France. Electronic address: g.noel@icans.eu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH